Projection-specific vulnerability to complement-mediated synaptic pruning drives distinct behavioral phenotypes

Target: C1QA Composite Score: 0.380 Price: $0.52▲7.3% Citation Quality: Pending Perioperative neurocognitive disorders Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
5
Citations
1
Debates
5
Supporting
2
Opposing
Quality Report Card click to collapse
D
Composite: 0.380
Top 84% of 1875 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
A Mech. Plausibility 15% 0.81 Top 13%
B Evidence Strength 15% 0.68 Top 24%
B+ Novelty 12% 0.72 Top 37%
B+ Feasibility 12% 0.78 Top 27%
F Impact 12% 0.00 Top 50%
F Druggability 10% 0.00 Top 50%
F Safety Profile 8% 0.00 Top 50%
F Competition 6% 0.00 Top 50%
F Data Availability 5% 0.00 Top 50%
F Reproducibility 5% 0.00 Top 50%
Evidence
5 supporting | 2 opposing
Citation quality: 44%
Debates
1 session A
Avg quality: 0.83
Convergence
0.00 F 7 related hypothesis share this target

From Analysis:

Why does prolonged anesthesia cause both cognitive dysfunction and anxiety through the same synaptic mechanism?

The study reports that complement-mediated synaptic elimination produces both cognitive deficits and anxiety-like behaviors, but doesn't explain how the same hippocampal synaptic loss generates these distinct behavioral phenotypes. This mechanistic gap limits understanding of perioperative neurocognitive disorders. Gap type: unexplained_observation Source paper: Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors. (2023, BMC Med, PMID:36600274)

→ View full analysis & debate transcript

Description

Prolonged anesthesia triggers complement activation (C1q/C3) that drives microglia-mediated synaptic elimination with projection-specific vulnerability. We hypothesize that ventral hippocampal neurons projecting to prefrontal cortex and amygdala lose synapses preferentially (mediating anxiety through disrupted top-down emotional regulation), while dorsal hippocampal neurons projecting to entorhinal cortex lose synapses preferentially (mediating cognitive deficits through impaired spatial memory encoding). This differential vulnerability is driven by region-specific synaptic molecular signatures (e.g., differential complement regulatory proteins, neuroligin/neurexin variants) that determine susceptibility to microglial C1q recognition and phagocytosis.

...

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["C1QA Expression
Complement C1q Alpha"] B["C1Q Complex
Assembly"] C["Synaptic Complement
Tagging"] D["Projection-Specific
Vulnerability"] E["Complement-Mediated
Pruning"] F["C1QA as Projection-Specific
Vulnerability Driver"] A --> B B --> C C --> D D --> E E --> F style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7 style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

GTEx v10 Brain Expression

JSON

Median TPM across 13 brain regions for C1QA from GTEx v10.

Spinal cord cervical c-174.7 Substantia nigra38.2median TPM (GTEx v10)

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.81 (15%) Evidence 0.68 (15%) Novelty 0.72 (12%) Feasibility 0.78 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.380 composite
7 citations 7 with PMID 5 medium Validation: 44% 5 supporting / 2 opposing
For (5)
5
No opposing evidence
(2) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
7
MECH 7CLIN 0GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
PubMed PMID 27033548SupportingMECHPubMed MEDIUM--PMID:27033548-
PubMed PMID 36915214SupportingMECHPubMed MEDIUM--PMID:36915214-
PubMed PMID 22632727SupportingMECHPubMed MEDIUM--PMID:22632727-
PubMed PMID 33558694SupportingMECHPubMed MEDIUM--PMID:33558694-
PubMed PMID 34472455SupportingMECHPubMed MEDIUM--PMID:34472455-
Sevoflurane-induced neurotoxicity can be ameliorat…OpposingMECH- MODERATE--PMID:41168320-
C1q-mediated synaptic elimination is robustly esta…OpposingMECH- MODERATE--PMID:41118244-
Legacy Card View — expandable citation cards

Supporting Evidence 5

PubMed PMID 27033548 MEDIUM
PubMed · PMID:27033548
PubMed PMID 36915214 MEDIUM
PubMed · PMID:36915214
PubMed PMID 22632727 MEDIUM
PubMed · PMID:22632727
PubMed PMID 33558694 MEDIUM
PubMed · PMID:33558694
PubMed PMID 34472455 MEDIUM
PubMed · PMID:34472455

Opposing Evidence 2

Sevoflurane-induced neurotoxicity can be ameliorated by rutin through antioxidant and NF-κB pathway inhibition… MODERATE
Sevoflurane-induced neurotoxicity can be ameliorated by rutin through antioxidant and NF-κB pathway inhibition independent of complement blockade, demonstrating that direct complement-mediated pruning is not the sole mechanism of anesthesia-induced synaptic loss
C1q-mediated synaptic elimination is robustly established during brain development but its role in adult perio… MODERATE
C1q-mediated synaptic elimination is robustly established during brain development but its role in adult perioperative neuroinflammation is mechanistically distinct and less well supported; adult microglial pruning involves alternative complement-independent engulfment pathways (MerTK, TREM2)
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-09 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Based on the knowledge gap regarding how complement-mediated synaptic elimination in the hippocampus produces both cognitive deficits and anxiety-like behaviors, here are my novel therapeutic hypotheses:

Hypothesis 1: Circuit-Specific Complement Targeting

Description: Different hippocampal circuits (CA1-prefrontal for cognition vs CA3-amygdala for anxiety) express distinct complement receptor profiles, making them differentially vulnerable to C1q/C3-mediated elimination. Selective complement inhibition could preserve cognitive circuits while allowing anxiety-related synaptic pruning to

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Now I'll provide my critical evaluation based on the available evidence:

Critical Evaluation of Therapeutic Hypotheses

Hypothesis 1: Circuit-Specific Complement Targeting

Specific Weaknesses:

  • The source paper (PMID:36600274) provides no evidence for distinct complement receptor profiles across hippocampal circuits
  • No data showing differential vulnerability of CA1-prefrontal vs CA3-amygdala pathways
  • Circuit-specific delivery systems for complement inhibitors remain hypothetical with no demonstrated feasibility
Counter-Evidence:
  • Studies show complement activation i

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

PRACTICAL FEASIBILITY ASSESSMENT

Based on my analysis of the provided hypotheses and literature, here's my assessment of druggability and commercial viability:

HYPOTHESIS 6: TEMPORAL COMPLEMENT ACTIVATION WINDOWS

Most Viable - Revised Confidence: 0.45

Druggability Assessment:

HIGH DRUGGABILITY - Complement cascade is well-established drug target
  • C3aR/C5aR antagonists: Multiple small molecules available
  • C1q inhibitors: ANX005 (Annexon Biosciences) - humanized monoclonal antibody
  • C3 inhibitors: Compstatin derivatives (APL-2/Pegcetacoplan, approved for

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

0.400.450.49 0.54 0.36 2026-04-212026-04-252026-04-28 Market PriceScoreevidencedebate 8 events
7d Trend
Stable
7d Momentum
▲ 11.3%
Volatility
High
0.1225
Events (7d)
7

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (7)

No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
Roles of neuropathology-associated reactive astrocytes: a systematic review.
Acta neuropathologica communications (2023) · PMID:36915214
No extracted figures yet
No extracted figures yet
No extracted figures yet

📅 Citation Freshness Audit

Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
32.3th percentile (776 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
5

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.430

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

📋 Reviews View all →

Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

💬 Discussion

No DepMap CRISPR Chronos data found for C1QA.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for C1QA →
Loading history…

⚖️ Governance History

No governance decisions recorded for this hypothesis.

Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

Browse all governance decisions →

Related Hypotheses

Complement C1q Mimetic Decoy Therapy
Score: 0.695 | neurodegeneration
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.678 | Alzheimer's Disease
Complement C1q Subtype Switching
Score: 0.665 | neurodegeneration
Complement-Mediated Synaptic Pruning Dysregulation
Score: 0.612 | neurodegeneration
Complement-Mediated Synaptic Protection
Score: 0.580 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions (2)

2 total 0 confirmed 0 falsified
IF C1q function is blocked selectively in ventral hippocampal (vHPC) projections to prefrontal cortex (PFC) via intra-vHPC injection of anti-C1q neutralizing antibody at the time of prolonged anesthesia (isoflurane 2 hours), THEN anxiety-like behavior (measured by elevated plus maze: >60 seconds in open arms; open field: >25% center time) will be significantly rescued at 7-14 days post-anesthesia, WHILE spatial reference memory performance (Morris water maze: escape latency >25 seconds on day 5; Barnes maze: >80 primary errors) will remain impaired and not differ from anesthesia-only controls.
pending conf: 0.65
Expected outcome: Selective rescue of anxiety phenotype with persistence of spatial memory deficits, manifesting within 2 weeks post-anesthesia
Falsified by: If both anxiety and spatial memory are rescued equally (no significant difference between pathway-specific and systemic C1q block), OR if anxiety persists despite vHPC-specific C1q inhibition, the projection-specific vulnerability model is falsified
Method: Adult C57BL/6J mice (8-12 weeks) undergoing 2-hour isoflurane anesthesia (1.5% MAC). Stereotactic injection of anti-C1q antibody (50µg/mouse, BioLegend #858001) or IgG control into vHPC (AP: -3.0, ML: ±3.5, DV: -3.0). Behavioral testing: elevated plus maze (day 7), open field (day 8), Morris water maze (days 9-13). Sample size n=12/group, power 0.8, α=0.05
IF C1q function is blocked selectively in dorsal hippocampal (dHPC) projections to entorhinal cortex via intra-dHPC infusion of C1q inhibitor (C1-INH, 100U/kg, Berinert) concurrent with prolonged anesthesia, THEN spatial memory encoding (measured by Barnes maze: <50 primary errors on day 4; novel object location: >65% discrimination index) will be rescued within 14-21 days post-anesthesia, WHILE anxiety-like behavior (elevated plus maze: <30 seconds open arm time; light-dark box: <120 seconds light side) will remain elevated and not differ from anesthesia-only controls.
pending conf: 0.60
Expected outcome: Selective rescue of spatial memory with persistence of anxiety phenotype, manifesting within 3 weeks post-anesthesia
Falsified by: If both anxiety and spatial memory are rescued equally following dHPC-specific C1q inhibition, OR if spatial memory remains impaired despite dHPC-specific intervention, the projection-specific differential vulnerability model is falsified
Method: Adult C57BL/6J mice (8-12 weeks) undergoing 2-hour isoflurane anesthesia (1.5% MAC). Intra-dHPC (AP: -2.0, ML: ±1.5, DV: -2.5) infusion of C1-INH or vehicle via osmotic pump (0.5µL/min over 30 min) peri-anesthesia. Behavioral testing: Barnes maze (days 10-14), novel object location (day 15), elevated plus maze (day 7). Synaptic density quantification via electron microscopy in entorhinal cortex terminals (post-mortem day 21). n=12/group

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

3D Protein Structure

🧬 C1QA — PDB 1PK6 Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

Why does prolonged anesthesia cause both cognitive dysfunction and anxiety through the same synaptic mechanism?

neurodegeneration | 2026-04-08 | completed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.